Drug Development
Discovering anti-TB drugs from natural sources requires multidisciplinary approach
Published in TB and Outbreaks Week, February 14th, 2006
According to a recent review from the United States, "The challenge of discovering new, urgently needed anti-TB drugs from natural sources requires a truly interdisciplinary research."
"Cutting-edge mycobacteriology and innovative natural products chemistry tools have to be developed and employed in tandem, in order to meet these demands," said G.F. Pauli and colleagues at Louisiana State University.
"The present review provides cross-linkage to the most recent literature on anti-TB active natural products and summarizes the recent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Diagnostics
Testing second urine samples increase sensitivity of Legionella urinary antigen assays - Epidemiology
Beijing genotype is major TB cause in Aral Sea region and is associated with drug resistance - Food Safety
Salmonella outbreaks caused by contaminated sesame seed-containing tahini - Norovirus Outbreaks
Norovirus gastroenteritis outbreak associated with contaminated wedding cakes - SARS
Subclinical transmission of SARS coronavirus low among household contacts - Allergy & Immunology
Mold from moisture-damaged buildings causes occupational asthma in Finland - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
